Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
Nucleic Acids Research|June 3, 2024
Unlocking the potential of protein-derived peptides to target G-quadruplex DNA: from recognition to anticancer activityFrancesco Merlino, Simona Marzano, Pasquale Zizza, et al.Journal of Medicinal Chemistry|April 27, 2017
Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer TreatmentErica Salvati, Lorenzo Botta, Jussara Amato, et al.Nucleic Acids Research|September 11, 2019
Insights into telomeric G-quadruplex DNA recognition by HMGB1 proteinJussara Amato, Linda Cerofolini, Diego Brancaccio, et al.Nature Communications|July 19, 2019
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitorsTimo Reisländer, Emilia Puig Lombardi, Florian J Groelly, et al.Journal of Medicinal Chemistry|October 13, 2012
Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell deathSandro Cosconati, Angela Rizzo, Roberta Trotta, et al.EMBO Molecular Medicine|February 2, 2022
Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumoursFlorian J Groelly, Manuela Porru, Jutta Zimmer, et al.International Journal of Molecular Sciences|December 1, 2020
Exploring the Interaction between the SWI/SNF Chromatin Remodeling Complex and the Zinc Finger Factor CTCFMariangela Valletta, Rosita Russo, Ilaria Baglivo, et al.Nucleic Acids Research|December 1, 2025
Modulating TERRA G-quadruplexes with ligands: impact on telomeric DNA:RNA hybrids and ALT mechanismsFederico Dinoi, Simona Marzano, Maria Ilaria Marino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
DNA damage persistence as determinant of tumor sensitivity to the combination of Topo I inhibitors and telomere-targeting agentsAnnamaria Biroccio, Manuela Porru, Angela Rizzo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumorsCarlo Leonetti, Marco Scarsella, Giuseppe Riggio, et al.Pageof 10